STE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Steris's sale of investment for the three months ended in Mar. 2024 was $0 Mil. It means Steris gained $0 Mil from selling investments. Steris's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was $0 Mil.
Compared with last quarter ($0 Mil in Dec. 2023 ), Steris gained the same money from selling investments in Mar. 2024 ($0 Mil).
The historical data trend for Steris's Sale Of Investment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Steris Annual Data | |||||||||||||||||||||
Trend | Mar15 | Mar16 | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | Mar24 | |||||||||||
Sale Of Investment | Get a 7-Day Free Trial | - | - | - | - | 3.88 |
Steris Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Sale Of Investment | Get a 7-Day Free Trial | - | - | - | - | - |
Sale of Investments represents cash inflow on the sale of investments in securities.
Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Steris's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard C Breeden | director | 100 SOUTH WACKER, SUITE 1800, CHICAGO IL 60606 |
Cynthia L Feldmann | director | 17 WINTHROP ROAD, WAYLAND MA 01778 |
Jacqueline B Kosecoff | director | 5960 HEISLEY ROAD, MENTOR OH 44060 |
Mohsen Sohi | director | C/O STERIS CORPORATION, 5960 HEISLEY ROAD, MENTOR OH 44060 |
Esther M. Alegria | director | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
Cary L Majors | officer: VP, N America Com Operations | 5960 HEISLEY ROAD, MENTOR OH 44060 |
John Adam Zangerle | director, officer: Sr. VP, Gen Counsel, and Sec. | 5960 HEISLEY ROAD, MENTOR OH 44060 |
Michael J Tokich | director, officer: Sr. Vice Pres., CFO | C/O STERIS CORP, 5960 HEISLEY RD, MENTOR OH 44060 |
Karen L Burton | officer: VP, Controller & CAO | 5960 HEISLEY ROAD, MENTOR OH 44060 |
Renato Tamaro | officer: V.P. & Corporate Treasurer | 5960 HEISLEY ROAD, MENTOR OH 44060 |
Andrew Xilas | officer: SVP and GM, Dental | 5960 HEISLEY ROAD, MENTOR OH 44060 |
Paul Edward Martin | director | C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, SUITE 100, BLUE BELL PA 19422 |
Julia Madsen | officer: Senior VP, Life Sciences | 5960 HEISLEY ROAD, MENTOR OH 44060 |
David B Lewis | director | |
Rosebrough Walter M Jr | officer: President & CEO | 5960 HEISLEY ROAD, MENTOR OH 44060 |
From GuruFocus
By sperokesalga sperokesalga • 05-10-2023
By GuruFocus Research • 09-11-2023
By Value_Insider Value_Insider • 10-25-2022
By GuruFocus Research • 11-08-2023
By Value_Insider Value_Insider • 11-09-2022
By Marketwired • 08-02-2023
By GuruFocusNews GuruFocusNews • 06-20-2022
By GuruFocus Research • 09-27-2023
By sperokesalga sperokesalga • 04-24-2023
By Marketwired • 08-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.